Alerts will be sent to your verified email
Verify Email
ALPA
|
Alpa Lab
|
Balaxi Pharma.
|
Krebs Biochem.&Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.02 % | 28.02 % | 37.05 % |
|
5yr average Equity Multiplier
|
1.26 | 1.4 | -2.13 |
|
5yr Average Asset Turnover Ratio
|
0.62 | 1.43 | 0.3 |
|
5yr Avg Net Profit Margin
|
13.26 % | 11.03 % | -55.19 % |
|
Price to Book
|
0.71 | 0.51 | 0.0 |
|
P/E
|
11.17 | 12.79 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
114.37 Days | 154.28 Days | -1144.52 Days |
|
Inventory Days
|
51.33 Days | 87.41 Days | 102.59 Days |
|
Days Receivable
|
142.78 Days | 103.86 Days | 8.23 Days |
|
Days Payable
|
94.49 Days | 63.18 Days | 623.06 Days |
|
5yr Average Interest Coverage Ratio
|
94.43 | 57.05 | -4.97 |
|
5yr Avg ROCE
|
13.16 % | 36.52 % | -23.43 % |
|
5yr Avg Operating Profit Margin
|
7.55 % | 16.64 % | -34.39 % |
|
5 yr average Debt to Equity
|
0.02 | 0.09 | -1.88 |
|
5yr CAGR Net Profit
|
21.88 % | -5.76 % | -0.84 % |
|
5yr Average Return on Assets
|
7.94 % | 18.47 % | -16.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.29 % | 65.99 % | 72.74 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -6.7 % | 0.02 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Alpa Lab
|
Balaxi Pharma.
|
Krebs Biochem.&Inds
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|